Information on GADI
The Global Adjuvant Development Initiative was created in response to the need for public sector vaccine developers to have access to appropriate safe and effective adjuvants. GADI is housed at WHO and serves as an umbrella initiative to bring together a network of adjuvant providers and users.
- To promote and facilitate access to adjuvants
- To promote access to information on adjuvants
- To promote technology transfer of adjuvants
- To facilitate evaluation of new adjuvants
HSeT content and learning activities are available under a
Creative Commons Attribution - Noncommercial - No Derivative Works 3.0 License
This site complies with the HONcode standard for trustworthy health information: verify here.